Cargando…

Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination

Detalles Bibliográficos
Autores principales: Rigamonti, C., Coco, B., Brunetto, M., Labanca, S., Giannini, E.G., Magro, B., Fagiuoli, S., Baroni, G. Svegliati, Sgamato, C., Miele, L., Grieco, A., Giuli, L., Manfredi, G.F., Pirisi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935163/
http://dx.doi.org/10.1016/j.dld.2022.01.093
_version_ 1784671987657867264
author Rigamonti, C.
Coco, B.
Brunetto, M.
Labanca, S.
Giannini, E.G.
Magro, B.
Fagiuoli, S.
Baroni, G. Svegliati
Sgamato, C.
Miele, L.
Grieco, A.
Giuli, L.
Manfredi, G.F.
Pirisi, M.
author_facet Rigamonti, C.
Coco, B.
Brunetto, M.
Labanca, S.
Giannini, E.G.
Magro, B.
Fagiuoli, S.
Baroni, G. Svegliati
Sgamato, C.
Miele, L.
Grieco, A.
Giuli, L.
Manfredi, G.F.
Pirisi, M.
author_sort Rigamonti, C.
collection PubMed
description
format Online
Article
Text
id pubmed-8935163
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89351632022-03-21 Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination Rigamonti, C. Coco, B. Brunetto, M. Labanca, S. Giannini, E.G. Magro, B. Fagiuoli, S. Baroni, G. Svegliati Sgamato, C. Miele, L. Grieco, A. Giuli, L. Manfredi, G.F. Pirisi, M. Dig Liver Dis P-59 Published by Elsevier Ltd. 2022-03 2022-03-21 /pmc/articles/PMC8935163/ http://dx.doi.org/10.1016/j.dld.2022.01.093 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle P-59
Rigamonti, C.
Coco, B.
Brunetto, M.
Labanca, S.
Giannini, E.G.
Magro, B.
Fagiuoli, S.
Baroni, G. Svegliati
Sgamato, C.
Miele, L.
Grieco, A.
Giuli, L.
Manfredi, G.F.
Pirisi, M.
Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title_full Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title_fullStr Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title_full_unstemmed Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title_short Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
title_sort clinical features of patients with new onset of autoimmune hepatitis following sars-cov-2 vaccination
topic P-59
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935163/
http://dx.doi.org/10.1016/j.dld.2022.01.093
work_keys_str_mv AT rigamontic clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT cocob clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT brunettom clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT labancas clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT gianninieg clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT magrob clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT fagiuolis clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT baronigsvegliati clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT sgamatoc clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT mielel clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT griecoa clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT giulil clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT manfredigf clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination
AT pirisim clinicalfeaturesofpatientswithnewonsetofautoimmunehepatitisfollowingsarscov2vaccination